RBC Europe’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q2 | $59K | Hold |
500
| – | – | ﹤0.01% | 313 |
|
2022
Q1 | $65K | Hold |
500
| – | – | ﹤0.01% | 324 |
|
2021
Q4 | $76K | Buy |
500
+25
| +5% | +$3.8K | ﹤0.01% | 313 |
|
2021
Q3 | $76.8K | Hold |
475
| – | – | ﹤0.01% | 474 |
|
2021
Q2 | $77.7K | Hold |
475
| – | – | ﹤0.01% | 485 |
|
2021
Q1 | $71.5K | Hold |
475
| – | – | ﹤0.01% | 475 |
|
2020
Q4 | $72K | Hold |
475
| – | – | ﹤0.01% | 437 |
|
2020
Q3 | $64.3K | Buy |
475
+370
| +352% | +$50.1K | ﹤0.01% | 415 |
|
2020
Q2 | $14.4K | Hold |
105
| – | – | ﹤0.01% | 688 |
|
2020
Q1 | $11.3K | Hold |
105
| – | – | ﹤0.01% | 678 |
|
2019
Q4 | $12.7K | Hold |
105
| – | – | ﹤0.01% | 751 |
|
2019
Q3 | $10.4K | Hold |
105
| – | – | ﹤0.01% | 782 |
|
2019
Q2 | $11.5K | Hold |
105
| – | – | ﹤0.01% | 778 |
|
2019
Q1 | $11.7K | Hold |
105
| – | – | ﹤0.01% | 777 |
|
2018
Q4 | $10.1K | Hold |
105
| – | – | ﹤0.01% | 782 |
|
2018
Q3 | $12.8K | Hold |
105
| – | – | ﹤0.01% | 792 |
|
2018
Q2 | $11.5K | Hold |
105
| – | – | ﹤0.01% | 821 |
|
2018
Q1 | $11.2K | Sell |
105
-495
| -83% | -$52.8K | ﹤0.01% | 813 |
|
2017
Q4 | $64.1K | Hold |
600
| – | – | 0.01% | 426 |
|
2017
Q3 | $66.7K | Buy |
+600
| New | +$66.7K | 0.01% | 427 |
|